Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Kedudukan dalam Saham #179
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Harga Saham
$44.60
Modal Pasaran
$108.62B
Perubahan (1 hari)
-1.63%
Perubahan (1 tahun)
-21.62%
Negara
FR
Perdagangan Sanofi (SNY)

Kategori

Pendapatan untuk Sanofi (SNY)
Pendapatan pada Dec 2025 TTM: $7.06B
Menurut laporan kewangan terkini Sanofi, pendapatan semasa syarikat ialah $7.06B. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $7.03B, peningkatan berbanding pendapatan pada tahun 2023 yang berjumlah $6.76B. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Sanofi dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $7.06B 0.00%
2025 $7.06B 0.44%
2024 $7.03B 4.03%
2023 $6.76B -36.93%
2022 $10.72B 20.27%
2021 $8.91B -48.24%
2020 $17.22B 410.31%
2019 $3.37B -40.13%
2018 $5.64B -16.37%
2017 $6.74B 10.21%
2016 $6.11B 7.85%
2015 $5.67B -16.42%
2014 $6.78B 9.05%
2013 $6.22B -23.52%
2012 $8.13B -0.71%
2011 $8.19B -14.33%
2010 $9.56B -3.08%
2009 $9.87B 45.83%
2008 $6.76B -25.57%
2007 $9.09B 43.73%
2006 $6.32B 95.83%
2005 $3.23B -3.31%
2004 $3.34B -15.22%
2003 $3.94B 49.74%
2002 $2.63B 21.90%
2001 $2.16B 43.20%
2000 $1.51B 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$25.73B 264.29%
US
$12.40B 75.59%
GB
$32.58B 361.29%
US
$6.60B -6.60%
US
$16.35B 131.51%
CH